awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33419633-1639FC47-ECDB-4975-9FEE-1B96E9181E8C
Q33419633-1639FC47-ECDB-4975-9FEE-1B96E9181E8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419633-1639FC47-ECDB-4975-9FEE-1B96E9181E8C
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma.
P2860
Q33419633-1639FC47-ECDB-4975-9FEE-1B96E9181E8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33419633-1639FC47-ECDB-4975-9FEE-1B96E9181E8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0678d10af11cd13b32a463382ceee8c9f18a2b2f
P2860
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.